Influence Market Failures: Fisons’ Collapse & Regulatory Missteps[2024]
Fisons plc’s 2024 collapse stands as a watershed moment in pharmaceutical regulatory history, exposing systemic vulnerabilities in managing influence markets—regulators, media, and advocacy groups. The UK-based firm’s demise, triggered by FDA sanctions over contaminated drugs and mishandled clinical trials, underscores how regulatory misalignment and media crises can dismantle decades-old reputations. This report dissects Fisons’ failures […]